Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Tepotinib's trials
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
Tepotinib
Ongoing
Active not recruiting
Phase 2
Open NCT02864992 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
NCT02864992 · Trial Tracker · ComplyRx
